Evaluating willingness-to-pay thresholds for dementia caregiving interventions: Application to the tailored activity program

Value in Health

Volumn 13, Issue 6, 2010, Pages 720-725

  Jutkowitz, Eric ^a   Gitlin, Laura N ^a   Pizzi, Laura T ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; contingent valuation method; outcomes of mental health care; willingness to pay

Indexed keywords

AGED; ARTICLE; CAREGIVER BURDEN; CLINICAL ARTICLE; CONTINGENT VALUATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEMENTIA; ECONOMIC EVALUATION; EVALUATION; FEMALE; HUMAN; MALE; MEDICAL FEE; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TAILORED ACTIVITY PROGRAM; WILLINGNESS TO PAY;

EID: 77956358886     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00739.x     Document Type: Article

References (35)

1. Wimo A, Winblad B, Jonsson L. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement 2007 3 : 81 91.
2. Moore MJ, Zhu CW, Clipp EC. Informal costs of dementia care: estimates from the national longitudinal caregiver study. J Gerontol B Psychol Sci Soc Sci 2001 56 (Suppl S219 28.
3. Zhu CW, Leibman C, McLaughlin T, et al. The effects of patient function and dependence on costs of care in Alzheimer's disease. J Am Geriatr Soc 2008 56 : 1497 1503.
4. Murman DL, Chen Q, Powell MC, et al. The incremental direct costs associated with behavioral symptoms in AD. Neurology 2002 59 : 1721 1729.
5. CohenMansfield JPD. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001 9 : 361 381.
6. Cohen-Mansfield JP. Nonpharmacological interventions for persons with dementia. Am J Geriatr Psychiatry 2005 6 : 129 145.
7. Lyketsos CG, Colenda CC, Beck C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006 14 : 561 573.
8. McDaid D. Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges. Int J Geriatr Psychiatry 2001 16 : 400 405.
9. Nichols LO, Chang C, Lummus A, et al. The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 2008 56 : 413 420.
10. Graff MJL, Adang EMM, Vernooij-Dassen MJM, et al. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ 2008 336 : 134 138.
11. Healthy People 2020. (Developmental) Reduce the proportion of unpaid caregivers of older adults who report an unmet need for caregiver support services (OA HP2020-2). Available from: http://www.healthypeople.gov/HP2020/ Objectives / [Accessed February 23, 2010 SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Exp Rev Pharmacoeconom Res 2008 8 : 165 178.
12. Gyrd-Hansen D. Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics 2005 23 : 423 432.
13. Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med 2006 62 : 2091 2100.
14. Chisholm D, Healey A, Knapp M. QALYs and mental health care. Soc Psychiatry Psychiatr Epidemiol 1997 32 : 68 75.
15. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines - similarities, differences and some implications. Value Health 2001 4 : 225 250.
16. Owens D. Interpretation of cost-effectiveness analyses. J Gen Intern Med 1998 13 : 716 717.
17. O'Brian B, Gafni A. When do the "dollars" make sense?: toward a conceptual framework for contingent valuation studies in health care. Med Decis Making 1996 16 : 288.
18. Bayoumia A. The measurement of contingent valuation for health economics. Pharmacoeconomics 2004 22 : 691.
19. Bala M, Mauskopf J, Wood L. Willingness to pay as a measure of health benefits. Pharmacoeconomics 1999 15 : 9.
20. Gitlin LN, Winter L, Vause Earland T, et al. The tailored activity program to reduce behavioral symptoms in individuals with dementia: feasibility, acceptability, and replication potential. Gerontologist 2009 49 : 428 439.
21. Gitlin LN, Winter L, Burke J, et al. Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. J Am Geriatr Soc 2008 16 : 229 239.
22. Gitlin LN, Hodgson N, Jutkowitz E, Pizzi LT. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry 16 December 2009 doi:10.1097/JGP.0b013e3181c37d13.
23. Folstein MF, Folstein SE, McHugh PR. "Mini mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 198.
24. Mahoney DF, Jones RN, Coon DW, et al. The caregiver vigilance scale: application and validation in the resources for enhancing Alzheimer's caregiver health (REACH) project. Am J Alzheimers Dis Other Demen 2003 18 : 39 48.
25. Gitlin L, Winter L, Corcoran M, et al. Effects of the home environmental skill building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH initiative. Gerontologist 2003 43 : 532 546.
26. Ory MG, Hoffman RR III., Yee JL, et al. Prevalence and impact of caregiving: a detailed comparison between dementia and nondementia caregivers. Gerontologist 1999 39 : 177 186.
27. Chiu L, Tang K, Liu Y, et al. Willingness of families caring for victims of dementia to pay for nursing home care: results of a pilot study in Taiwan. J Manag Med 1998 12 : 349.
28. Werner P, Schnaider-Beeri M, Aharon J, et al. Family caregivers' willingness to pay for drugs indicated for the treatment of Alzheimer's disease: an economic or psychological model? Dementia 2002 1 : 59 74.
29. Wu G, Lanctot KL, Herrmann N, et al. The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach. CNS Drugs 2003 17 : 1045 1057.
30. U.S. Bureau of Labor and Statistics. CPI inflation calculator. 2009. Available from: http://data.bls.gov/cgi-bin/cpicalc.pl [Accessed November 9, 2009 B, Bleichrodt H, Eeckhoudt L. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care. Health Econ 2005 14 : 363 376.
31. Van denBerg B, Brouwer W, van Exel J, Koopmanschap M. Economic valuation of informal care: the contingent valuation method applied to informal caregiving. Health Econ 2005 14 : 169 183.
32. Van den Berg B, Spauwen P. Measurement of informal care: an empirical study into the valid measurement of time spent on informal caregiving. Health Econ 2006 15 : 447 460.
33. Birch S, Gafni A. Cost effectiveness/utility analysis: do current decision rules lead us to where we want to be? J Health Econ 1992 12 : 469 476.
34. Tranmer JE, Guerriere DN, Ungar WJ, Coyte PC. Valuing patient and caregiver time: a review of the literature. Pharmacoeconomics 2005 23 : 449 459.
35. Russell LB. Completing costs: patients' time. Med Care 2009 47 (Suppl S89 93.